KRAS Mutations in Advanced Nonsquamous Non-Small-Cell Lung Cancer Patients Treated with First-Line Platinum-Based Chemotherapy Have No Predictive Value

Wouter W. Mellema, Anne-Marie C. Dingemans, Erik Thunnissen, Peter J. F. Snijders, Jules Derks, Danielle A. M. Heideman, Robertjan Van Suylen, Egbert F. Smit

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1190-1195
JournalJournal of Thoracic Oncology
Volume8
Issue number9
DOIs
Publication statusPublished - Sep 2013

Keywords

  • Non-small-cell lung cancer
  • Kirsten rat sarcoma viral oncogene homolog mutation
  • Predictive biomarker
  • Prognostic biomarker

Cite this